Not yet recruiting
Phase I-II PTCy, Bortezomib and Sitagliptin for Prevention of GvHD Following Allogeneic HSCT
NCT07675174
- Conditions
- GVHD - Graft-Versus-Host Disease, Graft vs Host Disease, Immune System Diseases
- Locations
-
- Northwell Health New Hyde Park, New York, United States